Jazz Pharmaceuticals PLC
NASDAQ:JAZZ

Watchlist Manager
Jazz Pharmaceuticals PLC Logo
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Watchlist
Price: 125.38 USD -1.78%
Market Cap: 7.7B USD
Have any thoughts about
Jazz Pharmaceuticals PLC?
Write Note

Jazz Pharmaceuticals PLC
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Jazz Pharmaceuticals PLC
Research & Development Peer Comparison

Comparables:
PRGO
AVDL
G
GHRS
COPN
OVB

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ
Research & Development
-$860.1m
CAGR 3-Years
-22%
CAGR 5-Years
-18%
CAGR 10-Years
-12%
Perrigo Company PLC
NYSE:PRGO
Research & Development
-$114m
CAGR 3-Years
3%
CAGR 5-Years
8%
CAGR 10-Years
3%
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Research & Development
-$12.3m
CAGR 3-Years
17%
CAGR 5-Years
19%
CAGR 10-Years
-5%
G
GH Research PLC
NASDAQ:GHRS
Research & Development
-$29.5m
CAGR 3-Years
-343%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cosmo Pharmaceuticals NV
SIX:COPN
Research & Development
-€21.3m
CAGR 3-Years
-16%
CAGR 5-Years
-9%
CAGR 10-Years
0%
Ovoca Bio PLC
LSE:OVB
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Jazz Pharmaceuticals PLC's Research & Development?
Research & Development
-860.1m USD

Based on the financial report for Sep 30, 2024, Jazz Pharmaceuticals PLC's Research & Development amounts to -860.1m USD.

What is Jazz Pharmaceuticals PLC's Research & Development growth rate?
Research & Development CAGR 10Y
-12%

Over the last year, the Research & Development growth was 27%. The average annual Research & Development growth rates for Jazz Pharmaceuticals PLC have been -22% over the past three years , -18% over the past five years , and -12% over the past ten years .

Back to Top